These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29107420)

  • 1. African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase.
    West RA; O'Doherty OG; Askwith T; Atack J; Beswick P; Laverick J; Paradowski M; Pennicott LE; Rao SPS; Williams G; Ward SE
    Eur J Med Chem; 2017 Dec; 141():676-689. PubMed ID: 29107420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward More Drug Like Inhibitors of Trypanosome Alternative Oxidase.
    West RA; Cunningham T; Pennicott LE; Rao SPS; Ward SE
    ACS Infect Dis; 2018 Apr; 4(4):592-604. PubMed ID: 29353481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
    Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of trypanocidal coumarins with dual inhibition of both the glycerol kinase and alternative oxidase of
    Balogun EO; Inaoka DK; Shiba T; Tsuge C; May B; Sato T; Kido Y; Nara T; Aoki T; Honma T; Tanaka A; Inoue M; Matsuoka S; Michels PAM; Watanabe YI; Moore AL; Harada S; Kita K
    FASEB J; 2019 Nov; 33(11):13002-13013. PubMed ID: 31525300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The trypanosome alternative oxidase: a potential drug target?
    Menzies SK; Tulloch LB; Florence GJ; Smith TK
    Parasitology; 2018 Feb; 145(2):175-183. PubMed ID: 27894362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological, and photophysical studies of molecular rotor-based fluorescent inhibitors of the trypanosome alternative oxidase.
    Cueto-Díaz EJ; Ebiloma GU; Alfayez IA; Ungogo MA; Lemgruber L; González-García MC; Giron MD; Salto R; Fueyo-González FJ; Shiba T; González-Vera JA; Ruedas Rama MJ; Orte A; de Koning HP; Dardonville C
    Eur J Med Chem; 2021 Aug; 220():113470. PubMed ID: 33940464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
    Ott R; Chibale K; Anderson S; Chipeleme A; Chaudhuri M; Guerrah A; Colowick N; Hill GC
    Acta Trop; 2006 Dec; 100(3):172-84. PubMed ID: 17126803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosome alternative oxidase: from molecule to function.
    Chaudhuri M; Ott RD; Hill GC
    Trends Parasitol; 2006 Oct; 22(10):484-91. PubMed ID: 16920028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore identification of ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei.
    Saimoto H; Kido Y; Haga Y; Sakamoto K; Kita K
    J Biochem; 2013 Mar; 153(3):267-73. PubMed ID: 23180806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
    Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
    Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosome alternative oxidase as a target of chemotherapy.
    Nihei C; Fukai Y; Kita K
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):234-9. PubMed ID: 12084465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
    Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
    ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.
    Bobba V; Nanavaty V; Idippily ND; Zhao A; Li B; Su B
    Bioorg Med Chem; 2017 Jun; 25(12):3215-3222. PubMed ID: 28428042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.
    Veerman J; van den Bergh T; Orrling KM; Jansen C; Cos P; Maes L; Chatelain E; Ioset JR; Edink EE; Tenor H; Seebeck T; de Esch I; Leurs R; Sterk GJ
    Bioorg Med Chem; 2016 Apr; 24(7):1573-81. PubMed ID: 26935942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.